Starting HIV therapy with a viral load above 100,000 is associated with a lower chance of achieving an undetectable viral load
Sharing drug preparation equipment a potential source of hepatitis C transmission
Low levels of vitamin D associated with poorer long-term CD4 cell gains in women who start HIV treatment late
Dutch find low bone mineral density in gay men, regardless of HIV infection status
Abacavir: new studies challenge the evidence of reduced potency when viral load is high
Telaprevir twice-daily works as well as every eight hours, safe for hepatitis C patients with cirrhosis
Which patients should be prioritised for new hepatitis C treatments?
Low viral load in hepatitis C treatment: Is a third drug necessary?
HIV test finder: a new tool for your smartphone and Facebook
